BidaskClub cut shares of Healthequity (NASDAQ:HQY) from a hold rating to a sell rating in a research note published on Saturday, BidAskClub reports.

Several other analysts also recently commented on HQY. TheStreet downgraded shares of Healthequity from a b rating to a c+ rating in a research report on Tuesday, September 3rd. Citigroup reiterated a buy rating on shares of Healthequity in a report on Friday, June 28th. Bank of America set a $79.00 target price on shares of Healthequity and gave the stock a buy rating in a research report on Wednesday, September 4th. Raymond James raised their target price on Healthequity from $85.00 to $90.00 and gave the company an outperform rating in a report on Friday, July 19th. Finally, Wells Fargo & Co reduced their price target on Healthequity from $80.00 to $76.00 and set an outperformer rating for the company in a research report on Wednesday, September 4th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Healthequity has a consensus rating of Buy and an average target price of $81.00.

HQY opened at $59.94 on Friday. The stock has a fifty day moving average price of $67.54 and a 200 day moving average price of $70.74. The company has a current ratio of 22.98, a quick ratio of 15.59 and a debt-to-equity ratio of 0.04. Healthequity has a 1 year low of $50.29 and a 1 year high of $101.58. The stock has a market cap of $3.76 billion, a price-to-earnings ratio of 63.09, a PEG ratio of 3.00 and a beta of 1.56.

Healthequity (NASDAQ:HQY) last issued its earnings results on Tuesday, September 3rd. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.26 by $0.10. The company had revenue of $86.60 million for the quarter, compared to analyst estimates of $85.33 million. Healthequity had a return on equity of 11.77% and a net margin of 28.13%. The business’s revenue was up 21.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.36 EPS. As a group, sell-side analysts forecast that Healthequity will post 0.93 earnings per share for the current fiscal year.

In related news, CFO Darcy G. Mott sold 4,000 shares of the business’s stock in a transaction dated Tuesday, August 20th. The stock was sold at an average price of $60.82, for a total transaction of $243,280.00. Following the completion of the transaction, the chief financial officer now owns 50,100 shares of the company’s stock, valued at approximately $3,047,082. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 6,875 shares of the stock in a transaction that occurred on Monday, July 22nd. The shares were sold at an average price of $80.00, for a total value of $550,000.00. Following the sale, the executive vice president now owns 17,833 shares of the company’s stock, valued at approximately $1,426,640. The disclosure for this sale can be found here. Insiders sold a total of 37,899 shares of company stock worth $2,751,451 over the last quarter. 3.70% of the stock is currently owned by company insiders.

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. BlackRock Inc. raised its position in shares of Healthequity by 13.1% during the second quarter. BlackRock Inc. now owns 7,268,685 shares of the company’s stock valued at $475,373,000 after buying an additional 840,177 shares during the last quarter. Vanguard Group Inc. increased its stake in Healthequity by 2.5% during the second quarter. Vanguard Group Inc. now owns 5,646,295 shares of the company’s stock valued at $369,268,000 after acquiring an additional 138,020 shares during the period. Invesco Ltd. increased its stake in Healthequity by 13.7% during the second quarter. Invesco Ltd. now owns 2,140,851 shares of the company’s stock valued at $140,012,000 after acquiring an additional 258,769 shares during the period. Janus Henderson Group PLC raised its holdings in Healthequity by 13.9% in the 2nd quarter. Janus Henderson Group PLC now owns 2,057,831 shares of the company’s stock valued at $134,582,000 after acquiring an additional 250,692 shares in the last quarter. Finally, Wasatch Advisors Inc. raised its holdings in Healthequity by 22.6% in the 1st quarter. Wasatch Advisors Inc. now owns 2,038,929 shares of the company’s stock valued at $150,840,000 after acquiring an additional 376,461 shares in the last quarter. 94.77% of the stock is currently owned by hedge funds and other institutional investors.

Healthequity Company Profile

HealthEquity, Inc provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the United States. The company offers healthcare saving and spending platform, a cloud-based platform for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Featured Article: Equity Income

Analyst Recommendations for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.